ARCHIVES

President’s Budget Request for FDA Omits Funding for Critical Path.

This article is from The Cancer Letter archive.

Vol. 34 No. 05 | February 8, 2008

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

NCI To Recomplete CIDAC Contracts

September 23, 1977